Will India Finally Ease Its Cannabis Laws? The July 2026 Deadline Explained

The July 2026 Deadline

Earlier this year, the Delhi High Court mandated a six-month policy review regarding India's cannabis laws under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. Sparked by a petition from the Great Legalisation Movement India Trust, the court directed the Centre to conduct thorough stakeholder consultations.

By July 2026, the Director General of the Narcotics Control Bureau (NCB), alongside medical experts and various ministries, must present their evaluation on whether the current stringent framework needs modernization.

Understanding the Current Law

India’s current approach to cannabis is highly nuanced. There is no absolute, blanket ban on the plant itself. Instead, the NDPS Act strictly criminalizes specific parts of the plant:

 Charas: The separated resin.

 Ganja: The flowering or fruiting tops (buds).

However, the law allows for the regulated cultivation of the plant for medical, scientific, and industrial purposes (such as hemp). Furthermore, bhang (the seeds and leaves) is entirely exempt from the NDPS Act and remains regulated at the individual state level.

The Ground Reality and Botanical Documentation

The demand and historical usage of the plant in India are immense. Recent data shows that approximately 31 million Indians have consumed a cannabis-related product in the past year. Because of the strict laws surrounding the flowers and resin, cannabis consistently accounts for the largest volume of narcotic seizures in the country, largely originating from the Eastern Ghats.

As policy reviews continue, there is hope that educational and scientific endeavors will benefit. Documenting India's rich botanical history—such as building digital archives and low-code applications to track the 34 famous indigenous cannabis strains—could become far more accessible for researchers, tech developers, and agriculturists. Clearer guidelines would empower creators to preserve this botanical knowledge safely and legally.

Weighing the Global Shift Against Local Risks

India’s reevaluation is happening at a time when the world is changing its stance. Countries like Canada and Germany have already loosened restrictions, and the World Health Organization has recommended reevaluating global controls.

Yet, the Indian government has valid concerns. Authorities have highlighted the risks of increased youth access, impaired driving, and the potential for poorly regulated "medical" cannabis to be diverted into the illegal recreational market.

What Happens Next?

As the July deadline draws closer, the Centre faces a critical choice. 

Will they maintain the status quo, introduce targeted reforms specifically for medical and industrial use, or open up a broader national debate on drug policy?

It is a developing story that sits at the intersection of law, medicine, and history. We will continue to monitor these updates as they unfold.

Source: For more detailed insights, you can read the full report at India Today.